4.7
Kronik Obstrüktif Akciğer Hastalığı III: Kronik Bronşit Özellikleri
Kronik bronşit, kronik obstruktif akciğer hastalığının (KOAH) önemli bir fenotipidir ve hava yolu merkezli iltihap ve mukus aşırı üretimiyle karakteri…
Kronik bronşit, KOAH'nin başlıca fenotiplerinden biri olup, sigara dumanı gibi havadan gelen tahriş edicilere uzun süre maruz kalmaktan kaynaklanır.
Bu tahriş ediciler, büyük bronşlarda başlayan ve küçük hava yollarına yayılan kalıcı iltihabı tetikler.
Nötrofiller, makrofajlar ve lenfositler bronş duvarlarına sızarak epitel hasarına yol açar.
İltihap ayrıca skuamöz metaplaziye yol açar; bu metaplaziye yol açar; bu da siliasyonlu epitelin yerine skuamöz hücreler oluşturur ve mukosiliyer klirensi bozar.
Bu arada, kadeh hücreleri ve submukozal bezler hiperplazi ve hipertrofi geçirerek kalın mukus üreterek hava yollarını tıkamış ve enfeksiyonu teşvik eder.
Sürekli iltihaplanma ve mukusun tıkanması, özellikle spirasyon sırasında hava yollarını daraltan düz kas hipertrofi ve fibroz gibi hava yollarının yeniden yapılanmasına yol açar.
Hava yolu tıkanıklığı, havalandırma-perfüzyon uyumsuzluğu yaratır ve bu da hipoksemiye yol açar. Kademeli hava hapsedilmesi, diyaframı düzleştiren, ventilasyon verimliliğini düşüren ve nefes alma işini artıran hiperenflasyona neden olur.
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic bronchitis to develop?
Chronic bronchitis develops from prolonged exposure to airborne irritants, most commonly cigarette smoke. These irritants trigger persistent inflammation that begins in the larger bronchi and extends into smaller airways. Neutrophils, macrophages, and lymphocytes infiltrate the bronchial walls, causing epithelial injury and initiating a cascade of structural and functional changes.
Q2: How does squamous metaplasia affect the airways in chronic bronchitis?
Squamous metaplasia replaces the ciliated epithelium with non-ciliated squamous cells, impairing mucociliary clearance. This loss of ciliated cells reduces the airway's ability to trap and remove mucus and pathogens, increasing infection risk and allowing mucus to accumulate and damage airways progressively.
Q3: Why do goblet cells and submucosal glands enlarge in chronic bronchitis?
Persistent inflammation triggers hyperplasia and hypertrophy of goblet cells and submucosal glands. These enlarged structures produce excessive, thick mucus that clogs airways and promotes bacterial colonization. The increased Reid index reflects glands occupying over half the bronchial wall thickness, contributing to airflow obstruction.
Q4: What is the relationship between airway remodeling and breathing difficulty?
Airway remodeling includes smooth muscle hypertrophy, fibrosis, and inflammatory thickening that narrow airways, especially during expiration. Combined with mucus plugging, this obstruction causes air trapping and hyperinflation, which flattens the diaphragm, reduces tidal volume, and significantly increases the work of breathing.
Q5: How does chronic bronchitis impair gas exchange?
Airway obstruction and mucus plugging create a ventilation-perfusion mismatch where perfusion exceeds ventilation. This mismatch leads to hypoxemia and, in advanced cases, hypercapnia due to poor carbon dioxide clearance. Progressive airway damage reduces the lungs' ability to oxygenate blood and eliminate carbon dioxide effectively.
Q6: What are the main clinical symptoms of chronic bronchitis?
Chronic bronchitis presents with chronic productive cough, dyspnea, and frequent infections. These symptoms result from persistent airway inflammation, excessive mucus production, and impaired clearance mechanisms. Although lung parenchyma is relatively preserved compared to emphysema, progressive airway damage leads to declining lung function and worsening symptoms.
Q7: How does chronic bronchitis differ from emphysema in COPD?
Chronic bronchitis is characterized by airway-centered inflammation and mucus overproduction with relatively preserved lung parenchyma. In contrast, emphysema involves parenchymal destruction. Understanding both phenotypes is essential for recognizing that chronic obstructive pulmonary disease emphysema and chronic bronchitis represent distinct pathological processes within COPD.